Construction of a Highly Targeted Therapeutic Nanoparticle for Osteoarthritis

Yuxiang Fei,Zhongyang Lv,Dongquan Shi
DOI: https://doi.org/10.1016/j.joca.2024.02.441
IF: 7.507
2024-01-01
Osteoarthritis and Cartilage
Abstract:Purpose (the aim of the study): Osteoarthritis (OA) is a complex and pervasive total joint degeneration. More than 250 million people worldwide are currently estimated to have OA, as the population ages, this number will only increase. At present, the clinically recognized treatment of osteoarthritis is mainly based on symptomatic treatment, which cannot effectively reverse the development of the disease. In recent years, many small molecule drugs have emerged. KGN has been proved to be a small molecule drug that can promote the chondrogenic differentiation of stem cells and protect chondrocytes in an inflammatory environment. Like other small molecule drugs, KGN is not targeted and is easily cleared by the constantly renewing synovial fluid. Like other small molecule drugs, KGN is not targeted and is easily cleared by the constantly renewing synovial fluid. In addition, low water solubility and abnormal proliferation of normal tissues are two other disadvantages of KGN. In this study, we aimed to construct a nanoparticle system that can carry small molecule drugs for the targeted treatment of OA.
What problem does this paper attempt to address?